Tag: investment
-
Start-Up Creating Off-the-Shelf Stem Cell Therapies
A new company is licensing technology from the lab of its co-founder at Harvard University to develop stem cell therapies for any recipients, without causing immune reactions.
-
NSF Funding Natural Agri-Chemical Technology
A start-up company spun-off from Cornell University is receiving a small business grant to develop in crop plants a natural protection against pathogens.
-
Infographic – Germany Beats U.K. in Top Venture Funds
A new analysis from technology market intelligence company GlobaData, based in London, shows the top 2 enterprises attracting venture financing in Europe during 2018 were German companies.
-
Crispr Diagnostics Company Launches with $35M Funding
Sherlock Biosciences Inc., a new enterprise offering medical diagnostics based on the genome-editing technology Crispr, is starting up with $35 million in seed financing.
-
Venture Funds, Mergers in A.I. Up Sharply in 2018
Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were highly prized acquisition targets in 2018, a new analysis shows.
-
Biogen Acquires Gene Therapy Company in $800M Deal
A company developing treatments for inherited eye diseases that replace malfunctioning with healthy genes is being acquired by biotechnology company Biogen.
-
Gene Therapy Company Acquired in $4.3B Deal
Spark Therapeutics, a biotechnology company that pioneered gene therapies, is being acquired by drug maker Roche Group in a deal valued at $4.3 billion.
-
Start-Up Raises $10.5M for Precision Immunotherapies
A new biotechnology enterprise developing personalized treatments that harness the immune system to treat cancer is raising $10.5 million in its first venture funding round.
-
MIT Spins-Off 32 Start-Ups in 2018
Research done at Massachusetts Institute of Technology in 2018 led to creation of 32 new start-up enterprises as well as hundreds of licenses and patents.
-
Company to Stop Cancer Spread, Relapse Raises $60.8M
A new company formed to commercialize research that aims to prevent cancer from spreading or recurring is raising $60.75 million in its first venture financing.